Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone and left ventricular remodelling after acute myocardial infarction
2004-004399-35Phase 4Completed
- Sponsor
- North Glasgow University Hospitals NHS Trust
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) and left ventricular systolic dysfunction (LVSD) comparing Eplerenone (Inspra) with Placebo (2 arms). Primary endpoint: Left ventricular end-systolic volume index (LVESV). Started Feb 2005; status: completed.
02
Drugs
eplerenone
03
Conditions
myocardial infarction (MI)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2004-004399-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004399-35.